Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jas Kalsi is active.

Publication


Featured researches published by Jas Kalsi.


BJUI | 2005

The results of plaque incision and venous grafting (Lue procedure) to correct the penile deformity of Peyronie's disease.

Jas Kalsi; Suks Minhas; Nim Christopher; David J. Ralph

Associate Editor


BJUI | 2002

The management of low‐flow priapism with the immediate insertion of a penile prosthesis

Rowland W. Rees; Jas Kalsi; Suks Minhas; J. Peters; P. Kell; David J. Ralph

Objective  To evaluate the outcome of patients undergoing the immediate insertion of a penile prosthesis as a treatment for acute low‐flow priapism.


BJUI | 2006

Plaque incision and fascia lata grafting in the surgical management of Peyronie's disease.

Jas Kalsi; Nim Christopher; David J. Ralph; Suks Minhas

To assess the outcome of using modified human fascia lata (TutoplastTM, Mentor Corp, Santa Barbara, CA, USA) in the surgical management of Peyronie’s disease (PD), as the penile deformity associated with PD can be corrected by plaque incision and saphenous vein grafting (Lue procedure).


Expert Opinion on Investigational Drugs | 2002

A Rho-kinase inhibitor, soluble guanylate cyclase activator and nitric oxide-releasing PDE5 inhibitor: novel approaches to erectile dysfunction.

Selim Cellek; Rowland W. Rees; Jas Kalsi

Approximately 50% of men aged over 40 suffer from male erectile dysfunction. Treatment options have widened since the launch of the phosphodiesterase type 5 (PDE5) inhibitor, sildenafil citrate (Viagra™). However, a certain portion of the patient population, such as diabetics, do not gain significant benefit from PDE5 inhibitors, possibly due to a lack of endogenous nitric oxide. Therefore, new treatment modalities based on the absence of endogenous nitric oxide have been developed. Among them are Rho-kinase inhibitors, soluble guanylate cyclase activators and nitric oxide-releasing PDE5 inhibitors. The available data concerning these compounds will be summarised and their therapeutic potential for male erectile dysfunction will be discussed.


BJUI | 2012

In the era of micro-dissection sperm retrieval (m-TESE) is an isolated testicular biopsy necessary in the management of men with non-obstructive azoospermia?

Jas Kalsi; Meen-Yau Thum; Asif Muneer; Hossam Abdullah; Suks Minhas

Study Type – Therapy (case series)


Reproductive Biomedicine Online | 2003

Novel PDE5 inhibitors for the treatment of male erectile dysfunction

Jas Kalsi; Gulam Bahadur; Asif Muneer; Ozkan Ozturk; Nim Christopher; David J. Ralph; Suks Minhas

Erectile dysfunction (ED) affects the lives of approximately 150 million men worldwide. ED may be a cause of male sub-fertility in a significant proportion of patients. There is now an expanding armamentarium for the management of ED, including oral agents such as phosphodiesterase type 5 (PDE5) inhibitors. PDE5 inhibitors may also be useful in situations of temporary ED in couples undergoing IVF. Two novel PDE5 inhibitors have been commercially launched in the European Union in the first quarter of 2003. This article reviews the pharmacology and clinical efficacy of these new agents and their potential role in treating patients with male sub-fertility.


BJUI | 2004

Plaque incision and grafting as a salvage after a failed Nesbit procedure for Peyronie's disease

Asif Muneer; Jas Kalsi; Nim Christopher; Suks Minhas; David J. Ralph

To analyse the outcome of plaque incision and grafting in patients who have a residual penile deformity after a Nesbit procedure for Peyronies disease, as a further Nesbit procedure may present difficulties in dissection at the previous operative site, and may result in further penile shortening.


BJUI | 2002

Massive bilateral angiomyolipomas resulting in respiratory failure

Jas Kalsi; Suks Minhas; Manit Arya; J.L. Peters; S.N. Venn; C.R.J. Woodhouse

A 35-year-old woman presented as an emergency complaining of right-sided abdominal pain, vomiting and abdominal distension. She also had a cough, increased difficulty in breathing and was febrile. Three years previously she had been diagnosed with tuberous sclerosis, bilateral renal angiomyolipomas (AMLs) and pulmonary lymphangio-leiomyomatosis (LAM). On admission her plasma creatinine level was 156 mmol/L and her haemoglobin level was 73 g/L. Initial management required intravenous resuscitation, broad-spectrum antibiotics and blood transfusion. At 72 h her respiratory and renal function deteriorated significantly and she was transferred to the intensive care unit for respiratory support and haemofiltration. Her respiratory function deteriorated further and the abdominal distension increased, requiring regular blood replacement and ultimately becoming transfusion dependent (although she was not haemodynamically compromised). CT of the abdomen revealed bleeding into the left kidney and retroperitoneal haemorrhage on the right side (Fig. 1). CT of the chest showed the abnormal features seen in LAM (Fig. 2). Renal angiography detected massively dilated renal arteries with the AMLs acting as arteriovenous shunts, but failed to identify active bleeding (Fig. 3); in view of her deteriorating clinical condition she underwent bilateral nephrectomy. At surgery two enormous kidneys were removed through a transverse anterior incision. The right kidney was 30 ¥ 21 ¥ 13 cm and weighed 3.828 kg, with the left kidney being even heavier (4.015 kg) and 30 ¥ 18 ¥ 1 cm. The patient made an impressive recovery, with normal respiratory function. Haemodialysis was commenced and the patient is currently awaiting a renal transplant.


The Journal of Urology | 2003

BAY41-2272, a novel nitric oxide independent soluble guanylate cyclase activator, relaxes human and rabbit corpus cavernosum in vitro.

Jas Kalsi; Rowland W. Rees; Adrian J. Hobbs; Michael Royle; Phil D. Kell; David J. Ralph; Salvador Moncada; Selim Cellek


European Urology Supplements | 2010

431 IN THE ERA OF MICRODISSECTION TESE-ARE THERE ANY HISTOPATHOLOGICAL/BIOCHEMICAL FACTORS PREDICTIVE FOR SUCCESSFUL SPERM RETRIEVAL IN MEN WITH SERTOLI CELL ONLY?

Jas Kalsi; E. Zacharakis; A. Muneer; Suks Minhas

Collaboration


Dive into the Jas Kalsi's collaboration.

Top Co-Authors

Avatar

Suks Minhas

University College Hospital

View shared research outputs
Top Co-Authors

Avatar

David J. Ralph

University College Hospital

View shared research outputs
Top Co-Authors

Avatar

Nim Christopher

University College London

View shared research outputs
Top Co-Authors

Avatar

Rowland W. Rees

University College London

View shared research outputs
Top Co-Authors

Avatar

Asif Muneer

University College Hospital

View shared research outputs
Top Co-Authors

Avatar

A. Muneer

University College London Hospitals NHS Foundation Trust

View shared research outputs
Top Co-Authors

Avatar

Selim Cellek

University College London

View shared research outputs
Top Co-Authors

Avatar

Phil D. Kell

University College London

View shared research outputs
Top Co-Authors

Avatar

Manit Arya

University College Hospital

View shared research outputs
Top Co-Authors

Avatar

Adrian J. Hobbs

Queen Mary University of London

View shared research outputs
Researchain Logo
Decentralizing Knowledge